Industry: Pharmaceuticals, Biotechnology
VistaGen Therapeutics is developing novel therapies for treatment of disorders of the Central Nervous System (CNS) and Peripheral Nervous System (PNS) (epilepsy and neuropathic pain, respectively) and metabolic disease (diabetes), each of which indications are multi-billion dollar markets with major unmet needs. To enhance its own internal drug discovery efforts and to generate short-term operating revenue, VistaGen also is leveraging its core embryonic stem cell technology platform through strategic collaborations with large pharmaceutical companies and through substantial nondilutive funding from the NIH, as well as future funding from the California Institute of Regenerative Medicine under California’s Stem Cell ( www.vistagen-inc.com )
VistaGen Therapeutics , Inc.
1450 Rollins Road
Burlingame, California 94010
USA
Tel: (650) 558-9500
Fax: (650) 558-9566